MetLife, Inc. (MET) Q1 2026 Earnings Call Transcript
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
Overview
The earnings call indicates strong financial metrics and optimistic guidance, particularly with expected double-digit EPS growth, robust free cash flow, and significant growth in various segments. The Q&A section reveals positive sentiment from analysts, with no major concerns raised. The PineBridge acquisition and strong sales in Asia further enhance growth prospects. Given these factors, the stock price is likely to experience a positive movement, despite the absence of a market cap, which would generally moderate the reaction.
Key Financial Performance
Adjusted Earnings $1.6 billion or $2.42 per share, increased 18% year-over-year. Adjusted earnings per share increased 23% year-over-year, driven by steady capital management.
Adjusted Premiums, Fees, and Other Revenues (excluding pension risk transfers) Increased 10% year-over-year, with broad-based growth across nearly all businesses and regions.
Variable Investment Income (VII) $518 million pretax, driven by higher private equity returns (approximately 2.9%) and strong venture capital performance.
Adjusted Return on Equity (ROE) 17%, at the top end of the 15%-17% target range, significantly above the cost of capital.
Direct Expense Ratio 11.9%, improved from last year and favorable relative to the full-year target of 12.1%, despite the integration of PineBridge.
Group Benefits Adjusted Earnings $439 million, up 19% year-over-year, driven by favorable life mortality trends and a light flu season. Total sales increased 15%, and adjusted PFOs (excluding participating contracts) rose 4%.
Retirement & Income Solutions (RIS) Adjusted Earnings $451 million, up 11% year-over-year, supported by strong variable investment income and favorable underwriting margins. New sales from U.K.-funded reinsurance and retail annuity reinsurance contributed $1.5 billion.
Asia Adjusted Earnings $487 million, up 31% year-over-year. Sales increased 22% on a constant currency basis, with Japan sales up 26% and Korea sales up 44%, driven by new product launches and strong economic conditions.
Latin America Adjusted Earnings $229 million, up 5% year-over-year, despite the impact of last year's tax change in Mexico. Sales increased 20%, and adjusted PFOs rose 11% on a constant currency basis.
EMEA Adjusted Earnings $110 million, up 33% year-over-year. Adjusted PFOs increased 15% on a constant currency basis, driven by strong sales of capital-light products.
MetLife Investment Management (MIM) Adjusted Earnings $47 million, up 68% year-over-year, following the integration of PineBridge. Institutional client assets under management decreased 1.9% sequentially due to market depreciation and modest net outflows.
Cash and Liquid Assets at Holding Companies $3.9 billion, at the top end of the $3 billion to $4 billion liquidity target buffer.
Shareholder Returns Approximately $1.1 billion returned to shareholders in the quarter, including $750 million in share repurchases and $370 million in common dividends.
You have reached the limit. Sign up to access full content
Get started
Operating Highlights
New Corporate Accident and Health Product in Japan: Introduced in the first quarter, contributing to a 26% increase in Japan sales on a constant currency basis.
Expansion in Asia: Strong sales performance with a 22% increase in the region on a constant currency basis, driven by Japan and Korea.
Growth in Latin America: Sales increased by 20% on a constant currency basis, with strong performance in Mexico, Chile, and Brazil.
Growth in EMEA: Adjusted earnings rose 33%, with adjusted PFOs up 15% on a constant currency basis, driven by capital-light products.
AI Integration: Invested over $3.2 billion in technology modernization over five years, embedding AI to improve decision-making, customer service, and operational efficiency.
Expense Management: Direct expense ratio improved to 11.9%, ahead of the 2026 target of 12.1%, reflecting strong expense discipline.
Divestment of Ukraine Business: Decision to divest the Ukraine business to position it for better growth under a new regional parent.
Capital Management: Returned $1.1 billion to shareholders in Q1 2026 through share repurchases and dividends, and issued $1 billion in subordinated debt to support growth.
You have reached the limit. Sign up to access full content
Get started
Risk or Challenges
Integration of PineBridge: The integration of PineBridge, a business with a structurally higher expense profile, could pose challenges in maintaining expense ratios and achieving cost efficiencies.
Disability and Paid Family Leave Costs: Higher average severity in disability claims and increased incidence from paid family leave could impact underwriting margins and profitability in the Group Benefits segment.
Private Equity and Investment Losses: The company experienced higher trading losses due to portfolio rotations and a modest loss from the sale of private equity limited partnership interests, which could affect investment income stability.
Institutional Client Outflows in MIM: MetLife Investment Management experienced approximately $2 billion in institutional client outflows during the quarter, reflecting market volatility and integration challenges with PineBridge.
Software and Software-Related Investments: Although the exposure is minor, the company has $2.5 billion in direct software investments and $6.3 billion in indirect exposure, which could pose risks if market conditions for technology companies deteriorate.
Economic Solvency Ratio in Japan: The economic solvency ratio in Japan is expected to be in the middle of the 170% to 190% target range, which could be a concern if it moves closer to the lower end of the range.
Higher Nonmedical Health Interest Adjusted Benefit Ratio: The nonmedical health interest adjusted benefit ratio was above the annual target range, driven by seasonally higher expectations for Dental and other factors, which could pressure margins.
You have reached the limit. Sign up to access full content
Get started
Guidance & Outlook
Group Benefits Outlook: Looking ahead, the company expects its market leadership, scale, and enduring customer relationships to drive growth in the U.S. life insurance market. Employers are anticipated to continue valuing benefits beyond medical coverage as a cost-effective way to support employees' health and financial security in a tight economy.
Retirement & Income Solutions (RIS) Outlook: The company sees substantial global retirement opportunities in markets like the U.S., U.K., and Japan, driven by demographic trends increasing demand for income. Newer additions like U.K.-funded reinsurance and retail annuity reinsurance are expected to reinforce product diversity and growth.
Asia Market Outlook: The company anticipates continued strong performance in Asia, particularly in Japan and Korea, driven by product innovation and demographic trends. Japan sales are expected to benefit from FX and yen-denominated products, while Korea's growth is supported by a solid economy and innovative products.
Latin America Market Outlook: The region is expected to maintain strong momentum, with growth driven by employee benefits in Mexico, retirement annuity demand in Chile, and expansion in Brazil.
EMEA Market Outlook: The company expects continued growth in EMEA, driven by a strategic focus on capital-light, accident and health, and life products. Strong sales across multiple markets are anticipated to contribute to adjusted earnings growth.
Artificial Intelligence (AI) Strategy: The company plans to continue embedding AI across core operations to improve decision-making, enhance customer service, and reduce costs. AI is expected to drive productivity and growth while maintaining strong governance and risk oversight.
Capital Management Outlook: The company plans to continue disciplined capital management, including share repurchases and dividend increases. It also aims to maintain a strong liquidity position, with cash at holding companies targeted at $3 billion to $4 billion.
Expense Management Outlook: The company is confident in achieving its 2026 direct expense ratio target of 12.1%, supported by ongoing efficiency measures and disciplined expense management.
You have reached the limit. Sign up to access full content
Get started
Shareholder Return Plan
Common Dividends Paid: MetLife paid common dividends of approximately $370 million in the first quarter of 2026.
Dividend Increase: The Board of Directors announced a 4.4% increase in MetLife's common dividend per share.
Share Repurchase: MetLife repurchased approximately $750 million of common shares in the first quarter of 2026 and an additional $200 million in April 2026.
Remaining Authorization: MetLife has $1.1 billion remaining on its existing share repurchase authorization.
You have reached the limit. Sign up to access full content
Get started
Key Q&A
Q:What is driving the improvement in working-age mortality trends in Group Life, and is this trend sustainable?
A:Ramy Tadros explained that the improvement in working-age mortality trends is influenced by various factors, including a pull-forward effect from COVID, the impact of GLP-1 drugs, and other elements under research. He noted that while favorable trends persist, any impact on pricing would occur gradually over years, not quarters.
Q:What is the status of regulatory actions in Japan and their impact on MetLife's franchise?
A:Lyndon Oliver stated that the regulatory issue is industry-wide and not specific to MetLife. The company has conducted a comprehensive review, returned seconded employees to their positions, and discontinued the practice. Discussions with regulators are ongoing and confidential. John McCallion added that there has been no impact on business results or sales.
Q:What drove the strong sales performance in Japan and the rest of Asia, and what is the outlook for the rest of the year?
A:Lyndon Oliver highlighted that sales in Japan grew 26% year-over-year due to distribution strength, successful product launches, and a diversified product portfolio. Sales in the rest of Asia grew 18%, driven by strong performance in Korea. While growth rates may moderate due to strong prior-year comparatives, momentum is expected to continue.
Q:What were the key drivers of non-medical health performance this quarter, and what is the outlook for the rest of the year?
A:Ramy Tadros identified three drivers: seasonally higher dental utilization, higher disability claims from new state-mandated paid family leave programs, and slightly elevated severity in LTD claims. He expects these impacts to moderate in the second half of the year.
Q:How are RIS spreads performing, and what is the outlook for core yield or spread?
A:John McCallion reported that RIS spreads were 119 basis points, at the top end of the guidance range. Core spreads were 95 basis points, with a slight sequential decline due to new flows from PRT mandates. He expects modest improvement in Q2 and total spreads to remain within the full-year range.
Q:What is MetLife's response to Sun Life's press release about a class action lawsuit?
A:Michel Khalaf stated that Sun Life's claims are baseless and misleading. MetLife was not named a defendant, and there are no legal proceedings between the parties. MetLife disputes any indemnity owed to Sun Life.
Q:What is the outlook for capital generation and statutory net income?
A:John McCallion explained that the 4% decline in statutory net income was due to dividend seasonality. He emphasized that capital generation remains strong, with a free cash flow ratio of 65%-75% and an RBC ratio of 379%, well above the 360% target.
Q:What is MetLife's strategy for investment allocations, particularly in commercial mortgage loans and private credit?
A:John McCallion noted that MetLife is being selective in commercial mortgage loans due to tight spreads. The company sees strong risk-adjusted returns in asset-backed financing and continues to leverage its diversified investment platform.
Q:What is the outlook for MetLife Investment Management (MIM) following the PineBridge acquisition?
A:John McCallion expressed optimism about MIM's future, citing progress in integration, client engagement, and pipeline development. PineBridge's international footprint is expected to enhance cross-selling opportunities, and the pipeline is well-diversified across asset classes and geographies.
Q:What is the competitive landscape in the group space, and what are the drivers of top-line growth?
A:Ramy Tadros reported 4% growth in group business, driven by improved persistency, strong sales momentum, and double-digit growth in voluntary products. He emphasized MetLife's competitive differentiators and value proposition.
Q:What is the outlook for EMEA earnings and the impact of the Middle East conflict?
A:Michel Khalaf stated that EMEA earnings are strong, with 2/3 coming from Europe. The Middle East conflict has not impacted operations, and any potential effects are expected to be immaterial to overall results. John McCallion added that EMEA earnings are trending toward the middle to upper end of the $90-$100 million quarterly range.
Q:What is the outlook for disability trends and potential repricing?
A:Ramy Tadros explained that while severity in LTD claims has been flat over the last three quarters, there is no evidence to warrant repricing. Paid family medical leave claims are expected to normalize, and MetLife can reprice 50% of the book annually.
Q:Review of Unclear Management Responses
A:Management avoided providing detailed explanations for the drivers of favorable working-age mortality trends, citing ongoing research and not elaborating on all potential factors. Additionally, discussions with Japanese regulators were described as confidential, limiting transparency on the issue's resolution.
You have reached the limit. Sign up to access full content
Get started
Earnings Word Cloud
The most frequently occurring keywords in this quarter's earning call
AI
Chief
Directors
Head Investor
Investor Relations
Japan market
MIM
MetLife New
Mexico
Officer
PFOs currency
United
accident health
action
annuity
balance sheet
benefit
confidence
cost
customer
decision
demand
dividend share
economy
employee
flexibility
improvement
increase
information
insurance
market Asia
offering
persistency
portfolio
presentation
product
reinsurance
resilience
sale PFOs
scale
sheet capital
start
strength
year
MET Transcript
MetLife, Inc. (MET) Q1 2026 Earnings Call Transcript
Positive5-7
The earnings call indicates strong financial metrics and optimistic guidance, particularly with expected double-digit EPS growth, robust free cash flow, and significant growth in various segments. The Q&A section reveals positive sentiment from analysts, with no major concerns raised. The PineBridge acquisition and strong sales in Asia further enhance growth prospects. Given these factors, the stock price is likely to experience a positive movement, despite the absence of a market cap, which would generally moderate the reaction.
MetLife, Inc. (MET) Presents at 47th Annual Raymond James Institutional Investor Conference Transcript
Neutral3-4
MetLife, Inc. (MET) Presents at Bank of America Financial Services Conference 2026 Transcript
Neutral2-10
MetLife, Inc. (MET) Q4 2025 Earnings Call Prepared Remarks Transcript
Unknown2-6
The earnings report shows a mix of positive and negative factors. While there are strong adjusted earnings, revenue growth, and shareholder returns, net derivative losses and less favorable underwriting in Asia present concerns. The acquisition of PineBridge and strong PRT transactions are positive, but integration risks exist. The market may react cautiously, resulting in a neutral stock price movement.
MET Slides
MET Report
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
